Companies People   

Home / Companies / Industries / Biotechnology and Drugs / Theravance, Inc. Overview


Theravance, Inc. Overview

State:California
Country:United States
Industry:Biotechnology and Drugs
Description:
Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates. As of December 31, 2009, the Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Its programs include VIBATIV (telavancin) with Astellas Pharma Inc. (Astellas) and its RELOVAI program (formerly referred to as Horizon) and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program with GlaxoSmithKline plc (GSK).... (More)










Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Please Enter a Valid Business Email



Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible